NNIT A/S (LON:0R5Z)
66.60
+0.90 (1.37%)
At close: Aug 1, 2025
Ligand Pharmaceuticals Market Cap
NNIT A/S has a market cap or net worth of 192.90 million as of August 1, 2025. Its market cap has decreased by -35.97% in one year.
Market Cap
192.90M
Enterprise Value
221.26M
Revenue
205.25M
Ranking
n/a
PE Ratio
1,739.63
Stock Price
$66.60
Market Cap Chart
Since March 6, 2015, NNIT A/S's market cap has decreased from 369.72M to 192.90M, a decrease of -47.82%. That is a compound annual growth rate of -6.06%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 192.90M | -24.60% |
Dec 30, 2024 | 255.83M | 5.19% |
Dec 29, 2023 | 243.20M | 25.28% |
Dec 30, 2022 | 194.13M | -39.31% |
Dec 30, 2021 | 319.87M | -11.92% |
Dec 30, 2020 | 363.17M | 16.02% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 175.60B |
HSBC Holdings | 160.06B |
Shell | 159.31B |
Unilever | 109.82B |
Rolls-Royce Holdings | 89.38B |
British American Tobacco p.l.c. | 88.30B |
Rio Tinto Group | 76.62B |
RELX PLC | 72.00B |